<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Tyrrell</First><Last>Conway</Last></Person>
    <Email>tconway@ou.edu</Email>
    <Department>Advanced Center for Genome Technology</Department>
    <Organization>University of Oklahoma</Organization>
    <Address>
      <Line>101 David L. Boren Blvd.</Line>
      <City>Norman</City>
      <State>OK</State>
      <Zip-Code>73019</Zip-Code>
      <Country>USA</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Person><First>Fabich</First><Last>Andrew</Last></Person>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Joe</First><Last>Grissom</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL6702">
    <Status database="GEO">
      <Submission-Date>2008-04-07</Submission-Date>
      <Release-Date>2008-04-08</Release-Date>
      <Last-Update-Date>2008-09-16</Last-Update-Date>
    </Status>
    <Title>Affymetrix Custom Array - enterocha520147F</Title>
    <Accession database="GEO">GPL6702</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>custom-commercial</Distribution>
    <Organism taxid="1392">Bacillus anthracis</Organism>
    <Organism taxid="99287">Salmonella enterica subsp. enterica serovar Typhimurium str. LT2</Organism>
    <Organism taxid="155864">Escherichia coli O157:H7 str. EDL933</Organism>
    <Organism taxid="199310">Escherichia coli CFT073</Organism>
    <Organism taxid="226185">Enterococcus faecalis V583</Organism>
    <Organism taxid="226186">Bacteroides thetaiotaomicron VPI-5482</Organism>
    <Organism taxid="386585">Escherichia coli O157:H7 str. Sakai</Organism>
    <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
    <Manufacturer>Affymetrix custom for Conway lab</Manufacturer>
    <Manufacture-Protocol>
Array with 511706 features, in 1 zones, with 24826 biosequences representing 254179 reporters and 24826 composite sequences, with surface type unknown
    </Manufacture-Protocol>
    <Description>
This array is designed for use with the 7 listed genomes.  Associated with each Series is a supplementary filter file that was used for data analysis.  The filter file contains only the probeset ID's for the associated Samples.
    </Description>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CDF">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/platforms/GPL6702/GPL6702_enterocha520147F.CDF.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>CDF_ID</Name>
        <Description>Corresponds to ID in GPL6702_enterocha520147F.CDF.gz</Description>
      </Column>
      <Column position="3">
        <Name>MG1655_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="4">
        <Name>MG1655_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="5">
        <Name>IG_GENE</Name>
        <Description>MG1655 intergenic region</Description>
      </Column>
      <Column position="6">
        <Name>EDL933_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="7">
        <Name>EDL933_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="8">
        <Name>O157_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="9">
        <Name>O157_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="10">
        <Name>CFT073_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="11">
        <Name>CFT073_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="12">
        <Name>LT2_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="13">
        <Name>LT2_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="14">
        <Name>V583_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="15">
        <Name>V583_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="16">
        <Name>VPI_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="17">
        <Name>VPI_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="18">
        <Name>pLT2_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="19">
        <Name>pLT2_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="20">
        <Name>pO157_ORF</Name>
        <Description>locus tag</Description>
      </Column>
      <Column position="21">
        <Name>pO157_GENE</Name>
        <Description>gene name</Description>
      </Column>
      <Column position="22">
        <Name>ORF</Name>
        <Description>ORF Name </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&amp;DB=gene&amp;cmd=search&amp;term=</Link-Prefix>
      </Column>
      <Column position="23">
        <Name>ORGANISM</Name>
      </Column>
      <Column position="24">
        <Name>SPOT_ID</Name>
      </Column>
    <External-Data rows="24826">
GPL6702-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM617014">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>WT-glucose-Rep1</Title>
    <Accession database="GEO">GSM617014</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli wild-type, A600=0.4 on glucose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
wild-type
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
WT_GLU_A.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617014/GSM617014.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617014-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617015">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>WT-glucose-Rep2</Title>
    <Accession database="GEO">GSM617015</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli wild-type, A600=0.4 on glucose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
wild-type
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
WT_GLU_B.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617015/GSM617015.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617015-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617016">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>MG1655star-glucose</Title>
    <Accession database="GEO">GSM617016</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli MG1655star, A600=0.4 on glucose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
MG1655star
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
MGstar_GLU.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617016/GSM617016.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617016-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617017">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>flhD-glucose</Title>
    <Accession database="GEO">GSM617017</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli flhD, A600=0.4 on glucose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
flhD
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
FlhD_GLU.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617017/GSM617017.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617017-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617018">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>WT-mannose</Title>
    <Accession database="GEO">GSM617018</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli wild-type, A600=0.4 on mannose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
wild-type
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
WT_MAN.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617018/GSM617018.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617018-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617019">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>MG1655star-mannose</Title>
    <Accession database="GEO">GSM617019</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli MG1655star, A600=0.4 on mannose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
MG1655star
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
MGstar_MAN.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617019/GSM617019.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617019-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617020">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>flhD-mannose</Title>
    <Accession database="GEO">GSM617020</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli flhD, A600=0.4 on mannose</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
flhD
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
FlhD_MAN.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617020/GSM617020.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617020-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617021">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>WT-mucus-P1</Title>
    <Accession database="GEO">GSM617021</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli wild-type, A600=0.2 on mucus</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
wild-type
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
WT_MUC_P1.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617021/GSM617021.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617021-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617022">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>MG1655star-mucus-P1</Title>
    <Accession database="GEO">GSM617022</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli MG1655star, A600=0.2 on mucus</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
MG1655star
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
MGstar_MUC_P1.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617022/GSM617022.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617022-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617023">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>flhD-mucus-P1</Title>
    <Accession database="GEO">GSM617023</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli flhD, A600=0.2 on mucus</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
flhD
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
FlhD_MUC_P1.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617023/GSM617023.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617023-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617024">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>WT-mucus-P2</Title>
    <Accession database="GEO">GSM617024</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli wild-type, A600=0.5 on mucus</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
wild-type
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
WT_MUC_P2.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617024/GSM617024.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617024-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617025">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>MG1655star-mucus-P2</Title>
    <Accession database="GEO">GSM617025</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli MG1655star, A600=0.5 on mucus</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
MG1655star
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
MGstar_MUC_P2.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617025/GSM617025.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617025-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM617026">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2010-11-03</Last-Update-Date>
    </Status>
    <Title>flhD-mucus-P2</Title>
    <Accession database="GEO">GSM617026</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli flhD, A600=0.5 on mucus</Source>
      <Organism taxid="511145">Escherichia coli str. K-12 substr. MG1655</Organism>
      <Characteristics tag="genotype/variation">
flhD
      </Characteristics>
      <Growth-Protocol>
Cells were grown at 37oC without shaking in 18 mm test tubes containing 5 ml of the MOPS-based culture medium designed by Neidhardt. Mouse cecal mucus was prepared from streptomycin-treated CD-1 mice (not colonized with E. coli). Cultures were grown to A600 = 0.4 in MOPS medium containing glucose or mannose (0.2%) and also in 10 mg/ml of lyophilized mucus at A600=0.2 (P1) or 0.5 (P2).
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Cultures were diluted into DNA-RNA Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified using RNeasy minkits with the optional DNase treatment (Qiagen).
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
RNA converted to cDNA by random-hexamer primed first strand synthesis with Superscript II and biotinylated with Roche Enzo kit according to Affymetrix protocol.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was at 60 degrees C for 16 h according to Affymetrix protocol ProkGE_WS2v2-450.
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix GCOS scanner software and GeneChip Scanner 3000.
    </Scan-Protocol>
    <Description>
FlhD_MUC_P2.CEL.CEL
    </Description>
    <Data-Processing>
RMA with quartile normalization according to method of Irizarry et al, 2003. The raw .cel files were processed in RMA using Bioconductor R package: affy Version:1.8.1 Date:2005-09-03, with the option Filter.genes containing a subset of probesets corresponding to MG1655 genes and intergenic regions listed in the matrix data. Replicates were averaged for ratio calculations.
    </Data-Processing>
    <Platform-Ref ref="GPL6702" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617026/GSM617026.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA normalized log2 intensity value</Description>
      </Column>
    <External-Data rows="5610">
GSM617026-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE25106">
    <Status database="GEO">
      <Submission-Date>2010-11-03</Submission-Date>
      <Release-Date>2010-11-04</Release-Date>
      <Last-Update-Date>2012-03-22</Last-Update-Date>
    </Status>
    <Title>Transcriptome of an intestine-adapted Escherichia coli K-12 mutant selected by animal passage for superior colonization</Title>
    <Accession database="GEO">GSE25106</Accession>
    <Pubmed-ID>21422176</Pubmed-ID>
    <Summary>
Transcription profiling of wild type E. coli MG1655, intestine-adapted E. coli MG1655star, and E. coli MG1655 flhD mutant grown on glucose, mannose, and mucus.
We previously isolated a spontaneous mutant of E. coli K-12, strain MG1655, following passage through the streptomycin-treated mouse intestine, which has colonization traits superior to the wild-type parent strain (Leatham, et. al., 2005, Infect Immun 73:8039-49) The intestine-adapted strain (E. coli MG1655star) grew faster on several different carbon sources compared to the wild-type and was non-motile due to deletion of the flhD gene. To further characterize E. coli MG1655star, we used several high-throughput genomic approaches. Whole-genome pyrosequencing did not reveal any changes on its genome, aside from the deletion at the flhDC locus, that could explain the colonization advantage of E. coli MG1655star. Microarray analysis revealed modest, yet significant induction of catabolic gene systems across the genome in both E. coli MG1655star and the isogenic flhD mutant. Catabolome analysis with Biolog GN2 Microplates revealed an enhanced ability of both E. coli MG1655star and the isogenic flhD mutant to oxidize a wide variety of carbon sources. The results show that intestine-adapted E. coli MG1655star is more fit than the wild-type for intestinal colonization because loss of FlhD results in elevated expression of genes involved in carbon and energy metabolism, leading to more efficient carbon source utilization, which results in a higher population size in the intestine. Hence mutations that enhance metabolic efficiency confer a colonization advantage.
    </Summary>
    <Overall-Design>
Three strains were profiled: E. coli MG1655 wildtype, E. coli flhD, and an intestine adapted strain, MG1655star, derived from the wildtype and isolated from feces after 15 days in the streptomycin treated mouse intestine, which proved to be a better colonizer than the wildtype, were grown on MOPS minimal medium containing 0.2% glucose or mannose, or mucus (10 mg/ml) and RNA was extracted from logarithmic phase cultures, and also from mucus grown cells in late log phase.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib2" position="1" />
    <Contributor-Ref ref="contrib3" position="2" />
    <Contributor-Ref ref="contrib1" position="3" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM617014" />
    <Sample-Ref ref="GSM617015" />
    <Sample-Ref ref="GSM617016" />
    <Sample-Ref ref="GSM617017" />
    <Sample-Ref ref="GSM617018" />
    <Sample-Ref ref="GSM617019" />
    <Sample-Ref ref="GSM617020" />
    <Sample-Ref ref="GSM617021" />
    <Sample-Ref ref="GSM617022" />
    <Sample-Ref ref="GSM617023" />
    <Sample-Ref ref="GSM617024" />
    <Sample-Ref ref="GSM617025" />
    <Sample-Ref ref="GSM617026" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE25106/GSE25106_RAW.tar
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE25106/GSE25106_normalized_ratio.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE25106/GSE25106_readme.txt
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/134497" />
  </Series>

</MINiML>
